Azur Innovation Fund Invests $1M in Morocco’s DataPathology to Revolutionize Cancer Diagnosis

Azur Innovation Fund, a public-private investment fund specialized in financing innovative startups in Morocco, continues its commitment to supporting young companies. After recently investing $1.1 million (11 million DH (Moroccan Dirhams) in PrestaFreedom, a home services platform focused on subscription-based cleaning and other services for individuals, the fund is now participating in the funding round of another promising startup called “DataPathology.” This demonstrates the fund’s ongoing interest in emerging enterprises with high-growth potential.

read alsoGlobal Health Institutions Need Africa

DataPathology, founded in 2020 by Mohammed El Khannoussi and Hicham El Attar, is a Moroccan MedTech startup specialized in pathology. The company has reached a significant milestone, successfully raising 2 million DH from the Witamax fund managed by Soax Partners a year and a half ago. Now, they have accomplished a similar feat by concluding a fundraising round of $1 million (10 million DH). This achievement was made possible through a partnership with Azur Innovation Fund, a private-public seed fund supported by Tamwilcom (formerly Caisse Centrale de Garantie) and managed by Azur Partners, led by Tarik Haddi, a specialist in fund management and investment advisory. This accomplishment aligns with the Innov Invest program.

Azur Innovation Fund DataPathology
Image: DataPathology

DataPathology’s mission is to address the lack of and delays in cancer diagnosis, particularly in medically underserved countries like those in Africa. The startup, co-founded by Hicham El Attar, a pathologist, and Mohammed El Khannoussi, an SI & Data consultant, aims to provide quick and secure pathological diagnosis to patients. Their innovative process involves conducting a biopsy and preparing a tissue sample at the patient’s examination site, digitizing it, and securely and anonymously transferring the digital file to the medical team for diagnosis through a web platform.

read also Morocco and United Kingdom Partners on Economy

DataPathology has already established partnerships with international players in digital health and has set up the first digital pathological diagnosis center in Morocco. They have also initiated discussions with African countries that show high potential for improving cancer diagnosis. As part of their future plans, the startup aspires to expand their network of laboratories in Morocco and Africa while strengthening the necessary infrastructure and logistics to increase the volume of data integrated and processed within their platform.

Azur Innovation Fund DataPathology Azur Innovation Fund DataPathology

Charles Rapulu Udoh

Charles Rapulu Udoh is a Lagos-based lawyer, who has several years of experience working in Africa’s burgeoning tech startup industry. He has closed multi-million dollar deals bordering on venture capital, private equity, intellectual property (trademark, patent or design, etc.), mergers and acquisitions, in countries such as in the Delaware, New York, UK, Singapore, British Virgin Islands, South Africa, Nigeria etc. He’s also a corporate governance and cross-border data privacy and tax expert. 
As an award-winning writer and researcher, he is passionate about telling the African startup story, and is one of the continent’s pioneers in this regard

Moroccan Health-tech Startup, DataPathology, Raises $223k From Witamax

DataPathology, a Casablanca-based MedTech startup focusing on digital pathology has raised $223k to transform the pathological diagnosis system and improve services for practitioners and patients. The funding came from Witamax, an investment firm founded by Southbridge A&I and the Axxam Family Office.

“DataPathology aims to assist hospitals, multidisciplinary clinics, and pathology centers in dealing with the rising number of cancer cases while also addressing the shortage of pathologists. This is accomplished by providing them with a comprehensive solution that enables them to provide a high-quality pathological diagnosis in a timely and efficient manner,” the startup noted in a statement. 

DataPathology’s goal with this investment is to quickly deploy more sites, expedite team recruiting, and establish themselves as a prominent leader in Medtech in Morocco and Africa.

DataPathology
Hicham El Attar is the co-founder and CEO of DataPathology. Image credits: DataPathology

A Look At What DataPathology Does

DataPathology, co-founded in 2020 by Hicham El Attar, pathologist and Mohammed El Khannoussi, SI & Data consultant, fights the lack of and delay in cancer diagnosis in medically destitute countries, particularly in Africa.

Read also

The startup team’s mission is to provide pathological diagnosis to patients quickly and securely through a process that involves preparing a human tissue sample on the patient’s examination site (biopsy), digitizing it, and then securely and anonymously transferring the patient’s digital file to the medical team for diagnosis via a web platform.

Read also Revolutionalising Legal Practice With Technology

“Having already forged partnerships with international players in digital health, installed a first digital pathological diagnosis center in the kingdom [of Morocco] and started serious discussions in African countries with high potential for cancer diagnosis, the startup today aspires to expand the network of laboratories in Morocco and Africa, then to consolidate the network and logistics necessary to increase the volume of data to be integrated and processed within the platform,” a statement from the statement further noted. 

Charles Rapulu Udoh

Charles Rapulu Udoh is a Lagos-based lawyer who has advised startups across Africa on issues such as startup funding (Venture Capital, Debt financing, private equity, angel investing etc), taxation, strategies, etc. He also has special focus on the protection of business or brands’ intellectual property rights ( such as trademark, patent or design) across Africa and other foreign jurisdictions.
He is well versed on issues of ESG (sustainability), media and entertainment law, corporate finance and governance.
He is also an award-winning writer